real-world evidence
The collaboration will increase the use cases for healthcare professionals to create care protocols and new treatments in oncology and promote precision medicine.
nference said researchers can use the de-identified clinical data to develop new therapeutics and diagnostics.
More expertise will be necessary if the regulator is to keep up with the constant evolution of real-world evidence, privacy and other data-driven challenges, Dr. Hahn said.
A frequent partner of biopharmas and the FDA, it has raised $94 million from investors since its commercial launch in 2015.
Scale Venture Partners headed the round, which comes roughly a year and a half after OM1's $21 million Series B.
In July, MobiHealthNews will focus on how pharma companies are using digital tools for R&D, real-world evidence collection and exploring new therapeutics.
The companies' partnership is yet another example of real-world data analysis coming to clinical trials.
The funding will fuel the company's international expansion as well as development of its analytics platform.
The Verisense platform is designed to address problems created by consumer devices in the clinical research world.
The new funding will primarily serve to expand the Aetion Evidence Platform.